Revisiting X-linked congenital ichthyosis

Area of Science:

• Genetics
• Dermatology
• Biochemistry

Background:

• X-linked recessive ichthyosis (XLI) is the second most prevalent ichthyosis subtype, affecting males primarily.
• It presents with generalized skin dryness, scaling, and potential extracutaneous symptoms.
• XLI is caused by mutations in the steroid sulfatase (STS) gene located on chromosome Xp22.3.

Purpose of the Study:

• To review the genetic, clinical, and pathological aspects of XLI.
• To elucidate the pathogenesis of XLI, focusing on STS deficiency and cholesterol sulfate accumulation.
• To discuss diagnostic approaches, differential diagnoses, and therapeutic strategies for XLI.

Main Methods:

• Literature review of genetic, clinical, and pathological studies on XLI.
• Analysis of the role of steroid sulfatase deficiency in epidermal barrier function.
• Synthesis of current knowledge on diagnosis and treatment options.

Main Results:

• STS gene deficiency leads to cholesterol sulfate accumulation in the stratum corneum.
• This accumulation impairs epidermal permeability barrier function and causes scaling.
• The review consolidates information on XLI's features, pathogenesis, and management.

Conclusions:

• Understanding STS gene variants is crucial for accurate XLI diagnosis and treatment.
• Further research may yield novel therapeutic and prenatal diagnostic strategies for XLI.
• Targeting STS gene function offers potential for improved XLI management.